TY  - JOUR
AU  - Bethencourt-Baute, Juan Jose
AU  - Sanchez-Piedra, Carlos
AU  - Ruiz-Montesinos, Dolores
AU  - Medrano-San-Ildefonso, Marta
AU  - Rodriguez-Lozano, Carlos
AU  - Perez-Pampin, Eva
AU  - Ortiz, Ana
AU  - Manrique, Sara
AU  - Rosello, Rosa
AU  - Hernandez, Victoria
AU  - Campos, Cristina
AU  - Sellas, Agusti
AU  - Sifuentes-Giraldo, Walter Alberto
AU  - Garcia-Gonzalez, Javier
AU  - Sanchez-Alonso, Fernando
AU  - Diaz-Gonzalez, Federico
AU  - Gomez-Reino, Juan Jesus
AU  - Bustabad-Reyes, Sagrario
PY  - 2018
DO  - 10.1186/s13075-018-1728-3
UR  - http://hdl.handle.net/10668/13057
T2  - Arthritis research & therapy
AB  - Biologic therapy has changed the prognosis of patients with juvenile idiopathic arthritis (JIA). The aim of this study was to examine the pattern of use, drug survival, and adverse events of biologics in patients with JIA during the period from...
LA  - en
PB  - BioMed Central
KW  - Biologic treatment
KW  - Clinical practice
KW  - Juvenile idiopathic arthritis
KW  - Safety therapy
KW  - Adolescent
KW  - Adult
KW  - Antirheumatic Agents
KW  - Arthritis, Juvenile
KW  - Biological Therapy
KW  - Child
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Humans
KW  - Middle Aged
KW  - Prospective Studies
KW  - Registries
KW  - Spain
KW  - Treatment Outcome
TI  - Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.
TY  - research article
VL  - 20
ER  -